Senate Democrats today staged an en masse boycott of a committee hearing on the Trump administration’s nominees to lead the U.S. Health & Human Services and Treasury Depts., forcing Republicans to delay the votes on Rep. Tom Price (R-Ga.) and Steve Mnuchin. At least 1 Democrat must be present for the Senate Finance committee votes to take […]
U.S. Treasury Dept.
Medtronic still unfazed by new inversion rules
Medtronic (NYSE:MDT) remains unfazed by the U.S. Treasury Dept.’s push to rein in so-called “inversion” mergers, which allow American companies to re-organized under foreign jurisdictions, after the agency issued new rules on the deals this week. The U.S. government has grappled with a wave of inversions in recent years, including last year’s $50 billion union of Medtronic and Covidien, […]
New inversion rules are unlikely to scuttle Medtronic’s pending $43B merger with Covidien | The week in medtech M&A

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy
September 24, 2014 by Brad Perriello
TriVascular Tech recall of stent grafts may drag down full-year revenues | Medtech Wall Street news for the week of September 22, 2014


TriVascular Tech's stent graft recall could hurt the bottom line
September 19, 2014 by Arezu Sarvestani

